PENICILLAMINE Side Effects

6947151-5 | Depression, Movement Disorder, Paranoia, Parkinsonism, Social Phobia, Tremor
on Aug 04, 2010 Female patient from UNITED KINGDOM , 17 years of age, was treated with Penicillamine (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), movement disorder (What is movement disorder?), paranoia, parkinsonism, social phobia, tremor. Penicillamine dosage: Oral. Patient was hospitalized.

6914361-2 | Completed Suicide, Mental Disorder
Patient was taking Penicillamine (View Usage). Patient had the following side effects: completed suicide, mental disorder on Jul 22, 2010 from JAPAN Additional patient health information: Male patient , 21 years of age, . Penicillamine dosage: .

6909510-6 | Acute Hepatic Failure, Anaemia, Duodenal Ulcer, Gastrointestinal Haemorrhage, Hypoalbuminaemia, Hypoprothrombinaemia, Iron Deficiency, Liver Injury
Adverse event was reported on Jul 22, 2010 by a Male patient taking Penicillamine (View Usage) (Dosage: ) . Location: JAPAN , 25 years of age, After Penicillamine was administered, patient had the following side effects: acute hepatic failure, anaemia, duodenal ulcer, gastrointestinal haemorrhage, hypoalbuminaemia, hypoprothrombinaemia, iron deficiency, liver injury. Patient was hospitalized.

6907249-4 | Acute Hepatic Failure, Blood Albumin Decreased, Depression, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Hypoprothrombinaemia, Incorrect Dose Administered, Iron Deficiency, Liver Injury
on Jul 22, 2010 Male patient from JAPAN , 36 years of age, weighting 196.2 lb, was treated with Penicillamine (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, blood albumin decreased, depression (What is depression?), gastrointestinal haemorrhage, haemoglobin decreased, hypoprothrombinaemia, incorrect dose administered, iron deficiency, liver injury. Penicillamine dosage: (600 Mg,per Day). Patient was hospitalized.


6765360-5 | Breech Presentation, Caesarean Section, Gestational Diabetes, Pregnancy
on May 25, 2010 Female patient from PORTUGAL , 35 years of age, was treated with Penicillamine (View Usage). Patient had the following side effects: breech presentation, caesarean section, gestational diabetes, pregnancy (What is pregnancy?). Penicillamine dosage: 900 Mg, Daily;. During the same period patient was treated with PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ).

6691338-6 | Antepartum Haemorrhage, Caesarean Section, Pregnancy, Premature Separation Of Placenta
Patient was taking Penicillamine (View Usage). After Penicillamine was administered, patient had the following side effects: antepartum haemorrhage, caesarean section, pregnancy (What is pregnancy?), premature separation of placenta on Apr 05, 2010 from GREECE Additional patient health information: Female patient , 28 years of age, . Penicillamine dosage: (1 Gm,per Day); (500 Mg,per Day). During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6666687-8 | Antimitochondrial Antibody Positive, Antinuclear Antibody Positive, Cholestasis, Hepatic Fibrosis, Hepatitis, Liver Injury
Adverse event was reported on Apr 01, 2010 by a Female patient taking Penicillamine (View Usage) (Dosage: ) . Location: UNITED STATES , 45 years of age, Patient experienced the following unwanted or unexpected effects: antimitochondrial antibody positive, antinuclear antibody positive, cholestasis, hepatic fibrosis, hepatitis (What is hepatitis?), liver injury.

6659730-3 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatic Neoplasm Malignant, Osteoarthritis, Psoriatic Arthropathy
on Mar 10, 2010 Female patient from TURKEY , 50 years of age, was treated with Penicillamine (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic neoplasm malignant, osteoarthritis (What is osteoarthritis?), psoriatic arthropathy. Penicillamine dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NONSTEROILDAL ANTIINFLAMMATORY (View Nonsteroildal Antiinflammatory Review and Nonsteroildal Antiinflammatory Label ).

6556638-9 | Abdominal Adhesions, Aortic Aneurysm, Aorto-duodenal Fistula, Back Pain, Blood Pressure Diastolic Increased, Culture Tissue Specimen Positive, Dizziness, Duodenitis, Gastritis
on Jan 14, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 48 years of age, was treated with Penicillamine (View Usage). After Penicillamine was administered, patient had the following side effects: abdominal adhesions, aortic aneurysm (What is aortic aneurysm?), aorto-duodenal fistula, back pain (What is back pain?), blood pressure diastolic increased, culture tissue specimen positive, dizziness (What is dizziness?), duodenitis, gastritis. Penicillamine dosage: (daily). During the same period patient was treated with ASPIRIN ((daily)) (View Aspirin Review and Aspirin Label ), NON STEROIDAL ANTIINFLAMMATORY ((daily)) (View Non-steroidal Antiinflammatory Review and Non-steroidal Antiinflammatory Label ), PREDNISOLONE ((daily)) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6521103-1 | Collapse Of Lung, Lung Neoplasm Malignant, Necrosis, Pleural Adhesion, Pleural Effusion, Respiratory Disorder, Respiratory Distress
Patient was taking Penicillamine (View Usage). Patient experienced the following unwanted or unexpected effects: collapse of lung, lung neoplasm malignant, necrosis, pleural adhesion, pleural effusion, respiratory disorder, respiratory distress on Dec 08, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with systemic sclerosis and. Penicillamine dosage: . Patient was hospitalized.

6491976-X | Dialysis, Haemolysis
Adverse event was reported on Nov 25, 2009 by a Female patient taking Penicillamine (View Usage) (Dosage: 2000 Mg Daily) . Location: DENMARK , 15 years of age, Patient had the following side effects: dialysis (What is dialysis?), haemolysis. Patient was hospitalized.

6129266-7 | Pancytopenia
on Mar 23, 2009 Male patient from UNITED STATES , 58 years of age, was diagnosed with systemic sclerosis and was treated with Penicillamine (View Usage). After Penicillamine was administered, patient had the following side effects: pancytopenia. Penicillamine dosage: 1250 Mg Every Day Po. Patient was hospitalized.

6101102-4 | Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis, Glomerulonephritis Rapidly Progressive, Renal Failure Acute
on Feb 13, 2009 Female patient from UNITED STATES , 70 years of age, was diagnosed with scleroderma (What is scleroderma?) and was treated with Penicillamine (View Usage). Patient experienced the following unwanted or unexpected effects: anti-neutrophil cytoplasmic antibody positive vasculitis, glomerulonephritis rapidly progressive, renal failure acute. Penicillamine dosage: 800 Mg Qd. Patient was hospitalized.

6021213-1 | Pleural Effusion, Pyrexia
Patient was taking Penicillamine (View Usage). Patient had the following side effects: pleural effusion, pyrexia on Dec 16, 2008 from GREECE Additional patient health information: Male patient , 31 years of age, . Penicillamine dosage: Oral; At Age 31.

5592568-7 | Cough, Duodenal Stenosis, Dyspepsia, Dyspnoea Exertional, Eructation, Intestinal Diaphragm Disease, Intestinal Stenosis, Nausea
Adverse event was reported on Dec 26, 2007 by a Female patient taking Penicillamine (View Usage) (Dosage: 500 Mg (500mg,1 In 1 D), Oral) was diagnosed with systemic sclerosis and. Location: JAPAN , 59 years of age, After Penicillamine was administered, patient had the following side effects: cough, duodenal stenosis, dyspepsia, dyspnoea exertional, eructation, intestinal diaphragm disease, intestinal stenosis, nausea (What is nausea?). Patient was hospitalized.

5283998-1 | Bronchial Obstruction, Lymphocytic Infiltration, Obliterative Bronchiolitis
on Mar 23, 2007 Female patient from JAPAN , 57 years of age, was diagnosed with arthritis (What is arthritis?) and was treated with Penicillamine (View Usage). Patient experienced the following unwanted or unexpected effects: bronchial obstruction, lymphocytic infiltration, obliterative bronchiolitis. Penicillamine dosage: 200mg Po Qd. Patient was hospitalized.

5271898-2 | Chromosome Analysis Abnormal, Chronic Myeloid Leukaemia, Crest Syndrome, Polyarthritis
on Feb 27, 2007 Female patient from TURKEY , 50 years of age, was diagnosed with scleroderma (What is scleroderma?) and was treated with Penicillamine (View Usage). Patient had the following side effects: chromosome analysis abnormal, chronic myeloid leukaemia, crest syndrome, polyarthritis. Penicillamine dosage: Po.

5271058-5 | Haemolysis, Jaundice, Liver Disorder, Mental Status Changes
Patient was taking Penicillamine (View Usage). After Penicillamine was administered, patient had the following side effects: haemolysis, jaundice (What is jaundice?), liver disorder, mental status changes on Mar 06, 2007 from TURKEY Additional patient health information: Female patient , 17 years of age, . Penicillamine dosage: . During the same period patient was treated with ZINC (View Zinc Review and Zinc Label ).

5268907-3 | Bedridden, Cardio-respiratory Arrest, Dystonia, Parkinsonism
Adverse event was reported on Feb 27, 2007 by a Female patient taking Penicillamine (View Usage) (Dosage: 900 Mg Daily) . Location: TURKEY , 77 years of age, Patient experienced the following unwanted or unexpected effects: bedridden, cardio-respiratory arrest, dystonia (What is dystonia?), parkinsonism. During the same period patient was treated with ZINC (ZINC) (View Zinc (zinc) Review and Zinc (zinc) Label ).

5268613-5 | Headache, Hepatic Failure, Sepsis
on Feb 27, 2007 Female patient from MALAYSIA , 33 years of age, was treated with Penicillamine (View Usage). Patient had the following side effects: headache (What is headache?), hepatic failure, sepsis (What is sepsis?). Penicillamine dosage: 250 Mg Qd, Po.

5189212-X | Blood Immunoglobulin A Decreased, Colitis Ulcerative, Rectal Ulcer
on Dec 04, 2006 Female patient from JAPAN , 56 years of age, weighting 70.55 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Penicillamine (View Usage). After Penicillamine was administered, patient had the following side effects: blood immunoglobulin a decreased, colitis ulcerative, rectal ulcer. Penicillamine dosage: 600 Mg/day; Oral.

4586910-3 | Arthritis, Arthropathy, Bone Disorder, Elastosis Perforans, Progeria, Scar
Patient was taking Penicillamine (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), arthropathy, bone disorder, elastosis perforans, progeria, scar (What is scar?) on Feb 16, 2005 from Additional patient health information: Female patient , weighting 140.0 lb, . Penicillamine dosage: .